Flatiron Health is a healthtech company focused on improving cancer care and advancing oncology research through real-world evidence. Founded in 2012, it became an independent affiliate of Roche in 2018 and operates globally.
The AI-driven precision medicine market is projected to grow from $0.7 billion in 2025 to $9.7 billion by 2035 at a 26.8% CAGR. North America dominates with 62-67% market share, while machine learning accounts for 39% of the market. The market is moderately consolidated with the top five players controlling over 64% share.
Flatiron Health announced its first Panoramic datasets for prostate cancer patients in the UK and Germany, encompassing records of nearly 400,000 patients across three countries. The datasets leverage AI and large language models to provide unified real-world evidence for cancer research.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06605404 |
Pan-tumor MRD Study |
RECRUITING |
